| TIL | tumor-infiltrating leukocyte; tumor-infiltrating lymphocyte |
|---|
| GIC | Graft-infiltrating cells |
|---|---|
| GIL | Graft-infiltrating lymphocytes |
| IDC | Infiltrating ductal carcinoma |
| ILC | Infiltrating lobular carcinoma |
| TIL | Tumor Infiltrating Lymphocytes |
| infiltrating | <pathology> Refers to a tumour that penetrates the normal, surrounding tissue. (13 Nov 1997) |
|---|---|
| infiltrating cancer | <oncology> Cancer that has grown through the cell wall of the breast area, in which it originated, and into surrounding tissues. (13 Nov 1997) |
| infiltrating ductal cell carcinoma | <oncology, tumour> A cancer that begins in the mammary glands and has spread to areas outside the gland. (13 Nov 1997) |
| infiltrating lipoma | A malignant tumour derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (liposarcoma, myxoid), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (12 Dec 1998) |
| carcinoma, infiltrating duct | An invasive (infiltrating) carcinoma of the breast. This carcinoma in which no special histological feature is recognised is designated nos or not otherwise specified and is by far the most common ductal tumour, accounting for almost 70% of breast cancers. It is characterised by stony hardness upon palpation. It commonly metastasizes to the axillary lymph nodes and its prognosis is the poorest of the various ductal types. (12 Dec 1998) |
|---|---|
| tumour-infiltrating lymphocyte | <haematology, oncology> Special cancer-fighting cells of the immune system found in tumours. In a type of experimental therapy, scientists harvest these cells from the tumour, grow them in a laboratory and then return them to the patient with the hope of the cells destroying the tumour. These cells can be collected from the site of a tumour and exposed to IL-2 in vitro. When these cells are injected back into the tumour bearing host, they will specifically kill the tumour from which they originated. (05 Mar 2000) |
| lymphocytes, tumour-infiltrating | Lymphocytes that show specificity for autologous tumour cells. Ex vivo isolation and culturing of til with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|